ClinicalTrials.gg
RecruitingNCT04173715MOBEMENTSUpdated May 8, 2024

Movement and Behaviours Measurement Study

An observational study in Aging, Physical Function and Frailty Syndrome, sponsored by University of Castilla-La Mancha. Recruiting at 1 site in Spain. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-08.

Sponsored by University of Castilla-La Mancha · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2019; still recruiting 7 years later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
90
Ages
65 Years and older
Sex
All
01

Study summary

There are few studies that already have validated specific raw accelerometer cut-points for people over 65 years old.

The purpose of the present study is to validate raw accelerometer cut points for general people over 65 years old and specific raw accelerometer cut points based on the functional status of older adults over 65 years old.

The study will be carried out with an observational approach. Participants will be divided into 4 groups. First of them will be made grouping all subjects and the rest divided according to their functional status. They will perform different-intensity physical activities while wearing accelerometers attached to their body and wearing a portable gas analyser too. Their intensity will be assessed based on their own Rest Metabolic Rate (RMR). Energy expenditure and accelerations will be matched and, based on that, sedentary behaviour, light physical activity and moderate-to-vigorous physical activity cut-points will be derived.

Read the detailed description

Knowledge on health implications of sedentary time and physical activity has been substantially improved in the last decades with accelerometer-based estimations. The popularity of these devices is partially explained by the capacity of objectively recording physical behaviors (e.g., sleep, sedentary time, physical activity…) during the whole day. The so-called "cut-point" approach is behind most of the research on physical activity with accelerometers. Cut-points provide metrics that are easy to understand, to translate to the public and to replicate by researchers in different settings. Usually, the minimum requirement is to use cut-points adapted to the age-group of the population of interest.

Under this paradigm, cut-points have been developed in all age-groups and with a variate set to data collection and processing protocols. However, some scenarios lack of available cut-points to implement, being older adults (> 65 years) the population with less alternatives of cut-points to use. In this sense, studies with older adults choose cut-points developed in younger adults to classify physical activity intensities. Biomechanical and physiological differences between adults and older adults advise against using this strategy. Therefore, relative energy expenditure and functional status should be considered for future cut-points design. Moreover, must be also awarded that hardly any previous cut-points validation protocols have been performed in a free-living setting. For this reason, more studies following these designs seems necessary to improve cut-points population's validity. Missing all mentioned factors could lead to physical activity and sedentary behavior patterns misclassification in this population.

02

Conditions studied

  • Aging
  • Physical Function
  • Frailty Syndrome
  • Physical Disability
  • Lifestyle, Sedentary

Keywords

  • Cut-Points
  • Accelerometry
  • Physical Activity Quantification
  • Physical Function
  • Frailty Syndrome
  • Energy Expenditure
  • Aging
03

In context

Frailty

1,229 studies on the registry are indexed under Frailty; 433 are open to participants now.

This study's planned enrollment of 90 is below the median of 211 across 503 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 107 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

People over 65 years old will be enrolled in the study. They will be recruited from the Frailty Consultation in the Virgen del Valle Hospital from Toledo (Spain).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 65 years and older
  • Non-institutionalized
  • Physical function assessment (SPPB>3)

Exclusion criteria

Exclusion Criteria:

  • Have started an exercise program.
  • Mini-Mental Score \< 18.
  • Presenting any physical activity contraindication.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
90 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • General Group

    All those who are over 65 years old and capable of walking by themselves.

    Behavioral: Older Adults Group.

  • Low Physical Function Status Group.

    All those who present a low physical function status will be included in this group.

    Behavioral: Low Physical Function Status Group · Behavioral: Medium Physical Function Status Group

  • Medium Physical Function Status Group.

    All those who present a medium physical function status will be included in this group.

    Behavioral: Low Physical Function Status Group · Behavioral: Medium Physical Function Status Group · Behavioral: High Physical Function Status Group

  • High Physical Function Status Group.

    All those who present a high physical function status will be included in this group.

    Behavioral: High Physical Function Status Group

Interventions

  • BehavioralOlder Adults Group.

    Physical activity and energy expenditure quantification

  • BehavioralLow Physical Function Status Group

    Physical activity and energy expenditure quantification

  • BehavioralMedium Physical Function Status Group

    Physical activity and energy expenditure quantification

  • BehavioralHigh Physical Function Status Group

    Physical activity and energy expenditure quantification

06

What researchers measure

Primary outcomes

  1. Rest Metabolic Rate

    (ml/kg-1/min-1)

    Time frame: Through study completion, an average of 1 year

  2. Energy expenditure during physical activity performance

    (ml/kg-1/min-1)

    Time frame: Through study completion, an average of 1 year

  3. Accelerometry

    Gravitational Units

    Time frame: Through study completion, an average of 1 year

  4. Physical function

    Short Physical Performance Battery

    Time frame: Through study completion, an average of 1 year

  5. Frailty Status

    Fried Frailty Index (0 criteria: Robust; 1-2 criteria: Pre-frail; \>2 criteria: Frail) and Frailty Trait Scale (from 0 (best score) to 100 (worst score))

    Time frame: Through study completion, an average of 1 year

  6. Physical Activity and Sedentary Behaviour Patterns.

    Accelerometers

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Heart Rate

    (bpm)

    Time frame: Through study completion, an average of 1 year

  2. Body composition

    Dual energy X-ray Absorptiometry (DXA)

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Universidad de Castilla-La Mancha, Laboratorio de Actividad Física y Función Muscular
    Toledo, 45071, Spain
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2019 (actual). Primary completion is estimated for Dec 2025, 74 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2019
First posted
Nov 22, 2019
StartActual
Oct 14, 2019
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
May 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04173715
Collaborators
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Responsible party
Ignacio Ara (Associate Professor, University of Castilla-La Mancha) — Principal investigator
First posted
Nov 22, 2019
Start date
Oct 14, 2019
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 8, 2024

Study contacts

Ignacio Ara Royo
Contact
Ignacio.Ara@uclm.es
+34 925268800 ext. 5543
Javier Leal Martín
Contact
javier.leal@uclm.es
+34 925268800 ext. 96808
Ignacio Ara Royo
principal investigator · Univeristy of Castilla-La Mancha

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion